Walsh Deina H has filed 7 insider transactions across 1 company since January 2023.
Most recent transaction: a grant/award of 8335 shares of Bone Biologics Corp ($BBLG) on January 08, 2026.
Activity breakdown: 3 open-market purchases and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 8, 2026 | Bone Biologics Corp | $BBLG | Walsh Deina H | Chief Financial Officer | A | Employee Stock Option | 8335 | $0.00 | 12,845.0000 | 1,795,260 | 184.81% | 0.46% |
| Jan. 15, 2025 | Bone Biologics Corp | $BBLG | Walsh Deina H | Chief Financial Officer | A | Employee Stock Option | 27055 | $0.00 | 39,633.0000 | 0 | 215.10% | 0.00% |
| Jan. 17, 2024 | Bone Biologics Corp | $BBLG | Walsh Deina H | Chief Financial Officer | A | Employee Stock Option | 12500 | $0.00 | 12,578.0000 | 0 | 9999.99% | 0.00% |
| Sept. 13, 2023 | Bone Biologics Corp | $BBLG | Walsh Deina H | Chief Financial Officer | P | Common Stock | 8000 | $0.64 | 15,000.0000 | 0 | 114.29% | 0.00% |
| Sept. 6, 2023 | Bone Biologics Corp | $BBLG | Walsh Deina H | Chief Financial Officer | P | Common Stock | 300 | $0.70 | 300.0000 | 0 | 9999.99% | 0.00% |
| Sept. 6, 2023 | Bone Biologics Corp | $BBLG | Walsh Deina H | Chief Financial Officer | P | Common Stock | 6700 | $0.71 | 7,000.0000 | 0 | 2233.33% | 0.00% |
| Jan. 25, 2023 | Bone Biologics Corp | $BBLG | Walsh Deina H | Chief Financial Officer | A | Employee Stock Option | 18875 | $0.00 | 43,875.0000 | 0 | 75.50% | 0.00% |